Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.
Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.
复制标题
DOI:
10.1002/hep.31228
复制
发表时间:
2020-12
期刊:
影响因子:
--
通讯作者:
Beraza N
中科院分区:
文献类型:
--
作者:
Isaacs-Ten A;Echeandia M;Moreno-Gonzalez M;Brion A;Goldson A;Philo M;Patterson AM;Parker A;Galduroz M;Baker D;Rushbrook SM;Hildebrand F;Beraza N
Mounting evidence supports an association between cholestatic liver disease and changes in the composition of the microbiome. Still, the role of the microbiome in the pathogenesis of this condition remains largely undefined. To address this, we have used two experimental models, administering alpha‐naphtylisocyanate or feeding a 0.1% 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine diet, to induce cholestatic liver disease in germ‐free mice and germ‐free mice conventionalized with the microbiome from wild‐type, specific pathogen‐free animals. Next, we have inhibited macrophage activation by depleting these cells using clodronate liposomes and inhibiting the inflammasome with a specific inhibitor of NOD‐, LRR‐, and pyrin domain‐containing protein 3. Our results demonstrate that cholestasis, the accumulation of bile acids in the liver, fails to promote liver injury in the absence of the microbiome in vivo. Additional in vitro studies supported that endotoxin sensitizes hepatocytes to bile‐acid–induced cell death. We also demonstrate that during cholestasis, macrophages contribute to promoting intestinal permeability and to altered microbiome composition through activation of the inflammasome, overall leading to increased endotoxin flux into the cholestatic liver. We demonstrate that the intestinal microbiome contributes to cholestasis‐mediated cell death and inflammation through mechanisms involving activation of the inflammasome in macrophages.
登录
查看更多内容
影响因子:
3.4
作者:
Capaldo, Christopher T.;Nusrat, Asma
通讯作者:
Nusrat, Asma
DOI:
10.1056/nejmra1506330
发表时间:
2016-09-22
期刊:
The New England journal of medicine
影响因子:
--
作者:
Lazaridis KN;LaRusso NF
通讯作者:
LaRusso NF
影响因子:
15.5
作者:
Langille MG;Meehan CJ;Koenig JE;Dhanani AS;Rose RA;Howlett SE;Beiko RG
通讯作者:
Beiko RG
影响因子:
6
作者:
Fickert, Peter;Stoeger, Ulrike;Trauner, Michael
通讯作者:
Trauner, Michael
DOI:
10.1097/01.meg.0000085466.12407.e9
发表时间:
2003-09-01
影响因子:
2.1
作者:
Di Leo, V;Venturi, C;Floreani, A
通讯作者:
Floreani, A